Datapoint

Datapoint: Anthem to Acquire InnovaCare’s Medicare Advantage, Medicaid Plans

Anthem, Inc. last week said it entered a deal to acquire InnovaCare Health’s MMM Holdings, the largest Medicare Advantage organization in Puerto Rico. InnovaCare currently enrolls 262,654 Medicare Advantage and ...
0 Comments
© 2024 MMIT

Datapoint: Oklahoma Awards Contracts for Medicaid Transformation

Oklahoma has selected Blue Cross Blue Shield of Oklahoma, Humana Inc., Centene Corp. and UnitedHealthcare to serve its new Medicaid managed care program, SoonerSelect. The transition is set to begin October 1,...
0 Comments
© 2024 MMIT

Datapoint: Blue Cross NC Expands Blue Premier to Kidney Care

Blue Cross and Blue Shield of North Carolina last week said it expanded Blue Premier, its value-based care program, to kidney care services. The program, a partnership with Blue Premier participants Strive Hea...
0 Comments
© 2024 MMIT

Datapoint: Biden to Order Special ACA Enrollment Period

President Joe Biden last week signed an executive order that will open a special enrollment period for HealthCare.gov, the federal platform for the Affordable Care Act exchanges, from Feb. 15 to May 15. The Preside...
0 Comments
© 2024 MMIT

Datapoint: Humana to Enter South Carolina Medicaid, Duals Market

Humana Inc. has been selected by the South Carolina Department of Health and Human Services to serve the state’s managed Medicaid program, as well as Healthy Connections Prime, a managed care initiative for Medi...
0 Comments
© 2024 MMIT

Datapoint: Health First Partners With Oscar for Member Tech Tools

Florida-based insurer Health First Health Plan on Tuesday said it has partnered with Oscar Health to leverage the startup’s array of tech tools. Health First’s Medicare Advantage and individual commercial member...
0 Comments
© 2024 MMIT

Datapoint: FDA Approves Aurinia’s Lupus Drug

The FDA last week approved Aurinia Pharma’s Lupkynis for the treatment of lupus nephritis, an inflammation of the kidneys in lupus patients that can lead to renal failure. This is the FDA’s second lupus nephriti...
0 Comments
© 2024 MMIT

Datapoint: Urovant Prepares for March Gemtesa Launch

Urovant Sciences is gearing up for a March launch of its first FDA-approved drug, Gemtesa, a beta-3 adrenergic receptor agonist which treats overactive bladder (OAB). The OAB market basket is rather crowded, a...
0 Comments
© 2024 MMIT

Datapoint: Fallon Health Brings Drug Pricing Tool to Medicare Advantage Members

Massachusetts-based Fallon Health on Jan. 7 unveiled a new effort to bring drug pricing transparency to seniors. The insurer has partnered with Rx Savings Solutions, a software company that offers free online tools ...
0 Comments
© 2024 MMIT

Datapoint: Merck and Bayer’s Verquvo Scores FDA Approval

The FDA on Tuesday approved Bayer and Merck & Co.’s blockbuster hopeful Verquvo for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). In the HFrEF market basket, the drug will ...
0 Comments
© 2024 MMIT